Register entry
allphamed Pharbil Arzneimittel GmbH
- Registered sites
- 1
- Drug products
- 6
- Live patents
- 0
- Countries
- 1
- Base
- Germany
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| allphamed Pharbil Arzneimittel GmbH | GottingenGermany | Finished drug manufacture, Packaging | 3008587095 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | BUMETANIDE | TABLET | DRUG FOR FURTHER PROCESSING |
| - | BUMETANIDE | TABLET | DRUG FOR FURTHER PROCESSING |
| - | BUMETANIDE | TABLET | DRUG FOR FURTHER PROCESSING |
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ANDA |
| Sephience | SEPIAPTERIN | POWDER | NDA |
| Sephience | SEPIAPTERIN | POWDER | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.